[go: up one dir, main page]

MX2017008087A - Virus de la viruela porcina recombinante y vacunas. - Google Patents

Virus de la viruela porcina recombinante y vacunas.

Info

Publication number
MX2017008087A
MX2017008087A MX2017008087A MX2017008087A MX2017008087A MX 2017008087 A MX2017008087 A MX 2017008087A MX 2017008087 A MX2017008087 A MX 2017008087A MX 2017008087 A MX2017008087 A MX 2017008087A MX 2017008087 A MX2017008087 A MX 2017008087A
Authority
MX
Mexico
Prior art keywords
vaccines
swinepox virus
recombinant swinepox
viruses
recombinant
Prior art date
Application number
MX2017008087A
Other languages
English (en)
Other versions
MX373809B (es
Inventor
Sato Takanori
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of MX2017008087A publication Critical patent/MX2017008087A/es
Publication of MX373809B publication Critical patent/MX373809B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24071—Demonstrated in vivo effect
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a novedosos virus de la viruela porcina recombinantes y a su uso en composiciones de vacuna. Los virus de la viruela porcina recombinantes de la invención se producen insertando uno o más genes foráneos en el gen de la proteína de unión a IL-18 (IL18bp) del virus de la viruela porcina. La invención es particularmente adecuada para producir vacunas porcinas, particularmente para vacunar cerdos contra una infección por PCV2.
MX2017008087A 2014-12-19 2015-12-18 Virus de la viruela porcina recombinante y vacunas. MX373809B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14307110.8A EP3034609A1 (en) 2014-12-19 2014-12-19 Recombinant swinepox virus and vaccines
PCT/EP2015/080468 WO2016097281A1 (en) 2014-12-19 2015-12-18 Recombinant swinepox virus and vaccines

Publications (2)

Publication Number Publication Date
MX2017008087A true MX2017008087A (es) 2017-10-31
MX373809B MX373809B (es) 2020-03-24

Family

ID=52345012

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008087A MX373809B (es) 2014-12-19 2015-12-18 Virus de la viruela porcina recombinante y vacunas.

Country Status (10)

Country Link
US (1) US10106819B2 (es)
EP (2) EP3034609A1 (es)
CN (1) CN107532151B (es)
CA (1) CA2969605C (es)
DK (1) DK3234159T3 (es)
ES (1) ES2748468T3 (es)
MX (1) MX373809B (es)
PH (1) PH12017501100A1 (es)
RU (1) RU2727899C2 (es)
WO (1) WO2016097281A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3254692A1 (en) * 2016-06-10 2017-12-13 Ceva Sante Animale Multivalent recombinant spv
EP3720485A1 (en) 2017-12-08 2020-10-14 Ceva Sante Animale Recombinant swinepox virus and vaccines
US20200405842A1 (en) * 2017-12-08 2020-12-31 Ceva Sante Animale Recombinant swinepox virus encoding a pcv3 antigen
CN113373119A (zh) * 2021-06-02 2021-09-10 江西农业大学 一种表达非洲猪瘟病毒三基因缺失重组伪狂犬病毒毒株、构建方法及其应用
CN117126292B (zh) * 2023-01-18 2025-07-04 北京大学 痘病毒重组嵌合抗原、包含其的免疫原性组合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2531729B2 (ja) 1987-03-27 1996-09-04 日本ゼオン株式会社 組み換えアビポックスウイルス
US5651972A (en) 1989-04-21 1997-07-29 University Of Florida Research Foundation, Inc. Use of recombinant swine poxvirus as a live vaccine vector
US6127163A (en) * 1992-01-13 2000-10-03 Syntro Corporation Recombinant swinepox virus
RU2076735C1 (ru) * 1994-03-23 1997-04-10 ГНЦВБ "Вектор" Живая рекомбинантная вакцина гепатита в на основе вируса осповакцины для перорального применения и способ ее получения
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP1816200B1 (en) 1997-12-11 2016-03-09 Merial Postweaning multisystemic wasting syndrome virus for pigs
EP2225367A1 (en) 2007-12-21 2010-09-08 Wyeth LLC Methods and compositions for immunizing pigs against porcine circovirus
EP2367933A1 (en) 2008-11-28 2011-09-28 Ceva Sante Animale Novel porcine circovirus type 2b isolate and uses thereof
EP2564869A1 (en) 2011-09-02 2013-03-06 Ceva Sante Animale Synthetic capsid proteins and uses thereof
EP2789346A1 (en) 2013-04-11 2014-10-15 CEVA Santé Animale SA Fusion polypeptides and vaccines

Also Published As

Publication number Publication date
MX373809B (es) 2020-03-24
CA2969605A1 (en) 2016-06-23
CN107532151B (zh) 2021-10-19
PH12017501100B1 (en) 2017-11-27
RU2017125494A (ru) 2019-01-21
EP3234159B1 (en) 2019-06-12
RU2727899C2 (ru) 2020-07-24
ES2748468T3 (es) 2020-03-16
BR112017012998A2 (pt) 2018-03-06
RU2017125494A3 (es) 2019-07-17
EP3034609A1 (en) 2016-06-22
US20170335343A1 (en) 2017-11-23
DK3234159T3 (da) 2019-09-23
PH12017501100A1 (en) 2017-11-27
WO2016097281A1 (en) 2016-06-23
EP3234159A1 (en) 2017-10-25
US10106819B2 (en) 2018-10-23
CN107532151A (zh) 2018-01-02
CA2969605C (en) 2023-06-20

Similar Documents

Publication Publication Date Title
BR112018011881A2 (pt) proteínas capsidiais modificadas para liberação aumentada de vetores de parvovírus
CL2018000432A1 (es) Vacunas terapéuticas contra el hpv18
AR133161A2 (es) Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
MX2017000169A (es) Un poliepitope quimerico de virus de dengue compuesto por fragmentos de proteinas no estructurales y su uso en una composicion inmunogenica contra infeccion de virus de dengue.
MX2017008087A (es) Virus de la viruela porcina recombinante y vacunas.
CO2017007105A2 (es) Nuevos virus de tilapia
MX2017008096A (es) Pestivirus.
AR101814A1 (es) Partícula de tipo virus flavivirus
MX377258B (es) Composiciones de vectores poxvirus y su uso para inducir una respuesta inmunitaria.
CO7461133A2 (es) Parvovirus 5a porcino, métodos de uso y vacuna
BR112018072372A2 (pt) combinações de vacina terapêutica contra o hpv
MX383506B (es) Parvovirus porcino.
BR112016019389A8 (pt) Vacina, e, peptídeo
BR112015023738B8 (pt) Vacinas de nucleoproteina influenza
CO7461135A2 (es) Parvovirus porcino 5b, métodos de uso y vacuna
CO2017005830A2 (es) Composiciones de vacuna para el virus del dengue
CO6700818A2 (es) Vectores de parapoxvirus
MX338052B (es) Vectores de parapoxvirus que contienen el antigeno del virus de la rabia.
PH12018502576A1 (en) Multivalent recombinant spv
MX2024007379A (es) Vacunas para el virus del papiloma humano y metodos para su uso.

Legal Events

Date Code Title Description
FG Grant or registration